Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Polycystic Ovary Syndrome 139 Breast Neoplasms 31 Prostatic Neoplasms 29 Insulin Resistance 28 Obesity 19 Pancreatic Neoplasms 13 Neoplasms 12 Infertility 12 Endometrial Neoplasms 12 Carcinoma, Non-Small-Cell Lung 12 Colorectal Neoplasms 11 Anovulation 9 Lung Neoplasms 8 Metabolic Syndrome 7 Melanoma 7 Hyperandrogenism 7 Glioblastoma 7 Diabetes Mellitus 7 Squamous Cell Carcinoma of Head and Neck 6 Neoplasm Metastasis 6 Rectal Neoplasms 5 Adenocarcinoma 5 Weight Loss 4 Urinary Bladder Neoplasms 4 Lymphoma, Large B-Cell, Diffuse 4 Head and Neck Neoplasms 4 Carcinoma, Ovarian Epithelial 4 Adenocarcinoma of Lung 4 Uterine Cervical Neoplasms 3 Recurrence 3

Interventions

Nivolumab 74 Sunitinib 73 pembrolizumab 49 Everolimus 39 Sorafenib 36 Bevacizumab 36 Axitinib 36 cabozantinib 35 Radiosurgery 33 Ipilimumab 33 pazopanib 32 Magnetic Resonance Spectroscopy 27 Interleukin-2 27 aldesleukin 23 Specimen Handling 22 Cyclophosphamide 21 lenvatinib 20 fludarabine phosphate 17 Radiotherapy 16 Interferon-alpha 15 Peripheral Blood Stem Cell Transplantation 14 Gemcitabine 14 Biopsy 14 temsirolimus 13 Nephrectomy 13 durvalumab 11 Immunohistochemistry 11 CTLA-4 Antigen 11 Blood Specimen Collection 11 Capecitabine 10

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Carcinoma, Renal Cell × Metformin × Clear all

NCT06884683 2025-03-19

NivoMet

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Phase 2 Terminated

Carcinoma, Renal Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡